![NETEC Resource Library](https://repository.netecweb.org/files/theme_uploads/400508e2d5d16a4cdb990b4486af9b3f.png)
Search Instructions:
* Filter the ENTIRE resource library: Choose a OR a to sort all resources.
* Choose Search Items : to filter one collection or perform complex queries.
* Choose Browse by Topic to search by one or more Topics.
Browse Items (107 total)
-
Creator: WHO
Subject: Treatment & Care
Item Type: Publication
Date Last Updated: 2019-05
Description: Considerable variability exists in the level of supportive care offered to Ebola patients, and this guideline provides recommendations for the management of adults and children to provide the best possible chance for survival. -
Creator: Centers for Disease Control and Prevention
Subject: General
Item Type: In Person Course
Date Last Updated: 2023-10-18
Description: These audiocasts, recorded at the SHEA/CDC ORTP Regional Training Workshop, discuss successes and failures of past infectious disease outbreaks and offer insights into the key steps involved in preparing your facility for the next high-consequence… -
Creator: Geleris, Joshua, Yifei Sun, Jonathan Platt, Jason Zucker, Matthew Baldwin, George Hripcsak, Angelena Labella, Daniel K. Manson, Christine Kubin, R. Graham Barr, Magdalena E. Sobieszczyk, and Neil W. Schluger.
Subject: Research
Item Type: Publication
Date Last Updated: 2020-06-18
Description: Hydroxychloroquine has been widely administered to patients with Covid-19 without robust evidence supporting its use. -
Creator: Liu, Yang, Jianying Liu, Hongjie Xia, Xianwen Zhang, Camila R. Fontes-Garfias, Kena A. Swanson, Hui Cai, Ritu Sarkar, Wei Chen, Mark Cutler, David Cooper, Scott C. Weaver, Alexander Muik, Ugur Sahin, Kathrin U. Jansen, Xuping Xie, Philip R.…
Subject: Research
Item Type: Publication
Date Last Updated: 2021-03-08
Description: BNT162b2 is a nucleoside-modified RNA vaccine expressing the full-length prefusion spike glycoprotein (S) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). In a randomized, placebo-controlled clinical trial involving approximately… -
Creator: NETEC
Subject: Emergency Management
Item Type: Webinar
Date Last Updated: 2022-11-09
Description: This NETEC webinar will discuss the current landscape of influenza in the United States and the predictions for this year’s flu season. Additional topics will include available therapeutics to treat common symptoms and co-infections and infection… -
Creator: NETEC
Subject: Treatment & Care
Item Type: Webinar
Date Last Updated: 2020-11-25
Description: In this webinar, we will identify important considerations involving Monoclonal Antibody Therapeutics available for emergency use authorization (EUAs) for mild-to-moderate COVID-19 cases, discuss recent criteria for the FDA approved investigational… -
Creator: NETEC
Subject: Treatment & Care
Item Type: Webinar
Date Last Updated: 2020-11-18
Description: In this webinar, we will discuss current evidence surrounding clinical trials for COVID-19 therapeutics including ACTT1, ACTT2, and ACTT3, and describe the FDA's Coronavirus Treatment Acceleration Program (CTAP) when determining new treatments for… -
Creator: University of Nebraska Medical Center / Nebraska Medicine
Subject: General
Item Type: Webinar
Date Last Updated: 2018-01-08
Description: Resources - National Ebola Training and Education CenterExample only: NETEC provides this item for reference purposes but does not endorse its content. Newer versions may be in place at the providing institution.
-
Creator: the Overcoming COVID-19 Investigators
Subject: Treatment & Care
Item Type: Publication
Date Last Updated: 2021-06-16
Description: The assessment of real-world effectiveness of immunomodulatory medications for multisystem inflammatory syndrome in children (MIS-C) may guide therapy. -
Creator: NETEC
Subject: Treatment & Care
Item Type: Guide
Date Last Updated: 2020-12-10
Description: This printable flyer infographic discusses mAb for COVID-19. Monoclonal antibody therapeutics (mAb) are one of the first available medical countermeasure therapeutics for mild-to-moderate COVID-19 cases. This handout discusses what they are, the…